Published in J Biol Chem on November 08, 2010
Pancreatic Beta Cell-derived IP-10/CXCL10 Isletokine Mediates Early Loss of Graft Function in Islet Cell Transplantation. Diabetes (2017) 1.39
Human β-cell proliferation and intracellular signaling part 2: still driving in the dark without a road map. Diabetes (2014) 1.37
ATF2 - at the crossroad of nuclear and cytosolic functions. J Cell Sci (2012) 1.20
MicroRNA-30d induces insulin transcription factor MafA and insulin production by targeting mitogen-activated protein 4 kinase 4 (MAP4K4) in pancreatic β-cells. J Biol Chem (2012) 1.19
The soluble Decoy Receptor 3 is regulated by a PI3K-dependent mechanism and promotes migration and invasion in renal cell carcinoma. Mol Cancer (2013) 1.00
The Roles of Mitogen-Activated Protein Kinase Pathways in TGF-β-Induced Epithelial-Mesenchymal Transition. J Signal Transduct (2012) 0.94
Inflammatory response in islet transplantation. Int J Endocrinol (2014) 0.91
miR-296-3p, miR-298-5p and their downstream networks are causally involved in the higher resistance of mammalian pancreatic α cells to cytokine-induced apoptosis as compared to β cells. BMC Genomics (2013) 0.88
Widespread JNK-dependent alternative splicing induces a positive feedback loop through CELF2-mediated regulation of MKK7 during T-cell activation. Genes Dev (2015) 0.86
The transcription factor Myt3 acts as a pro-survival factor in β-cells. PLoS One (2012) 0.81
Cannabidiol (CBD) enhances lipopolysaccharide (LPS)-induced pulmonary inflammation in C57BL/6 mice. J Immunotoxicol (2012) 0.79
GnRH regulation of Jun and Atf3 requires calcium, calcineurin, and NFAT. Mol Endocrinol (2012) 0.78
RNA-Seq reveals a role for NFAT-signaling in human retinal microvascular endothelial cells treated with TNFα. PLoS One (2015) 0.78
NFATc2 is an intrinsic regulator of melanoma dedifferentiation. Oncogene (2015) 0.76
NFAT targets signaling molecules to gene promoters in pancreatic β-cells. Mol Endocrinol (2014) 0.76
EPO-cyclosporine combination therapy reduced brain infarct area in rat after acute ischemic stroke: role of innate immune-inflammatory response, micro-RNAs and MAPK family signaling pathway. Am J Transl Res (2017) 0.75
Islet adaptation to obesity and insulin resistance in WNIN/GR-Ob rats. Islets (2014) 0.75
Identification and characterization of novel immunomodulatory bursal-derived pentapeptide-II (BPP-II). J Biol Chem (2011) 0.75
The role of MafA in regulating cytokine expression in pancreatic beta cells. J Biol Chem (2011) 0.75
Effect of lysophosphatidic acid on the immune inflammatory response and the connexin 43 protein in myocardial infarction. Exp Ther Med (2016) 0.75
The Transcription Factor Nfatc2 Regulates β-Cell Proliferation and Genes Associated with Type 2 Diabetes in Mouse and Human Islets. PLoS Genet (2016) 0.75
Anti-high mobility group box-1 (HMGB1) antibody attenuates kidney damage following experimental crush injury and the possible role of the tumor necrosis factor-α and c-Jun N-terminal kinase pathway. J Orthop Surg Res (2017) 0.75
Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes. Cell (1991) 15.76
Transcription factors of the NFAT family: regulation and function. Annu Rev Immunol (1997) 11.57
The mechanism of action of cyclosporin A and FK506. Immunol Today (1992) 7.57
Pathologic anatomy of the pancreas in juvenile diabetes mellitus. Diabetes (1965) 6.00
Mechanisms of pancreatic beta-cell death in type 1 and type 2 diabetes: many differences, few similarities. Diabetes (2005) 5.54
The proto-oncogene c-maf is responsible for tissue-specific expression of interleukin-4. Cell (1996) 5.13
Inflammation and activated innate immunity in the pathogenesis of type 2 diabetes. Diabetes Care (2004) 4.88
The immunosuppressant FK506 selectively inhibits expression of early T cell activation genes. J Immunol (1989) 4.30
Nuclear localization of NF-ATc by a calcineurin-dependent, cyclosporin-sensitive intramolecular interaction. Genes Dev (1997) 3.29
Inhibition of T cell signaling by immunophilin-ligand complexes correlates with loss of calcineurin phosphatase activity. Biochemistry (1992) 3.05
Anti-tumor necrosis factor-alpha blockade improves insulin resistance in patients with rheumatoid arthritis. Clin Exp Rheumatol (2006) 2.80
Regulation of the hypothalamic-pituitary-adrenal axis by cytokines: actions and mechanisms of action. Physiol Rev (1999) 2.77
c-maf promotes T helper cell type 2 (Th2) and attenuates Th1 differentiation by both interleukin 4-dependent and -independent mechanisms. J Exp Med (1998) 2.58
Islet inflammation in type 2 diabetes: from metabolic stress to therapy. Diabetes Care (2008) 2.36
Effect of tumor necrosis factor alpha on insulin-dependent diabetes mellitus in NOD mice. I. The early development of autoimmunity and the diabetogenic process. J Exp Med (1994) 2.33
Immunohistochemical characterization of monocytes-macrophages and dendritic cells involved in the initiation of the insulitis and beta-cell destruction in NOD mice. Diabetes (1994) 2.17
NFATx, a novel member of the nuclear factor of activated T cells family that is expressed predominantly in the thymus. Mol Cell Biol (1995) 2.13
Prevention of diabetes in nonobese diabetic mice by tumor necrosis factor (TNF): similarities between TNF-alpha and interleukin 1. Proc Natl Acad Sci U S A (1990) 2.13
Cell-type-restricted binding of the transcription factor NFAT to a distal IL-4 enhancer in vivo. Immunity (2000) 2.13
Identification and purification of functional human beta-cells by a new specific zinc-fluorescent probe. J Histochem Cytochem (2001) 2.08
Tumor necrosis factor alpha gene regulation in activated T cells involves ATF-2/Jun and NFATp. Mol Cell Biol (1996) 2.03
Inflammation-mediated dysfunction and apoptosis in pancreatic islet transplantation: implications for intrahepatic grafts. J Leukoc Biol (2005) 2.00
Increased interleukin (IL)-1beta messenger ribonucleic acid expression in beta -cells of individuals with type 2 diabetes and regulation of IL-1beta in human islets by glucose and autostimulation. J Clin Endocrinol Metab (2008) 1.91
The role of T-cells in the pathogenesis of Type 1 diabetes: from cause to cure. Diabetologia (2003) 1.73
Cell-type-specific regulation of the human tumor necrosis factor alpha gene in B cells and T cells by NFATp and ATF-2/JUN. Mol Cell Biol (1996) 1.66
Discovery of gene networks regulating cytokine-induced dysfunction and apoptosis in insulin-producing INS-1 cells. Diabetes (2003) 1.63
Requirement for transcription factor NFAT in interleukin-2 expression. Mol Cell Biol (1999) 1.56
Islet cell survival determined by morphology. An immunocytochemical study of the islets of Langerhans in juvenile diabetes mellitus. Diabetes (1978) 1.52
A dual role for TNF-alpha in type 1 diabetes: islet-specific expression abrogates the ongoing autoimmune process when induced late but not early during pathogenesis. J Immunol (2001) 1.51
ERK1/2-dependent activation of transcription factors required for acute and chronic effects of glucose on the insulin gene promoter. J Biol Chem (2005) 1.48
IL-1 produced and released endogenously within human islets inhibits beta cell function. J Clin Invest (1998) 1.46
Pharmacological agents that directly modulate insulin secretion. Pharmacol Rev (2003) 1.45
Transgenic tumor necrosis factor (TNF)-alpha production in pancreatic islets leads to insulitis, not diabetes. Distinct patterns of inflammation in TNF-alpha and TNF-beta transgenic mice. J Immunol (1993) 1.45
Identification of novel cytokine-induced genes in pancreatic beta-cells by high-density oligonucleotide arrays. Diabetes (2001) 1.43
Local expression of transgene encoded TNF alpha in islets prevents autoimmune diabetes in nonobese diabetic (NOD) mice by preventing the development of auto-reactive islet-specific T cells. J Exp Med (1996) 1.39
Dendritic cells and macrophages are the first and major producers of TNF-alpha in pancreatic islets in the nonobese diabetic mouse. J Immunol (1998) 1.30
Monocyte chemoattractant protein-1 is expressed in pancreatic islets from prediabetic NOD mice and in interleukin-1 beta-exposed human and rat islet cells. Diabetologia (2001) 1.28
The temporal importance of TNFalpha expression in the development of diabetes. Immunity (2000) 1.27
Improvement of insulin sensitivity in insulin resistant subjects during prolonged treatment with the anti-TNF-alpha antibody infliximab. Eur J Clin Invest (2004) 1.26
In autoimmune diabetes the transition from benign to pernicious insulitis requires an islet cell response to tumor necrosis factor alpha. J Exp Med (1999) 1.25
The effect of immunosuppressive agents on the induction of nuclear factors that bind to sites on the interleukin 2 promoter. J Exp Med (1990) 1.18
Local expression of TNFalpha in neonatal NOD mice promotes diabetes by enhancing presentation of islet antigens. Immunity (1998) 1.17
IFN-gamma gene expression in pancreatic islet-infiltrating mononuclear cells correlates with autoimmune diabetes in nonobese diabetic mice. J Immunol (1995) 1.15
Regulation of insulin gene transcription by a Ca(2+)-responsive pathway involving calcineurin and nuclear factor of activated T cells. Mol Endocrinol (2001) 1.14
The CD40L promoter contains nuclear factor of activated T cells-binding motifs which require AP-1 binding for activation of transcription. J Biol Chem (1996) 1.14
Lymphokine gene expression in vivo is inhibited by cyclosporin A. J Exp Med (1990) 1.14
Adipose tissue inflammation: novel insight into the role of macrophages and lymphocytes. Curr Opin Clin Nutr Metab Care (2010) 1.13
Effects of cyclosporin A and FK506 on Fc epsilon receptor type I-initiated increases in cytokine mRNA in mouse bone marrow-derived progenitor mast cells: resistance to FK506 is associated with a deficiency in FK506-binding protein FKBP12. Proc Natl Acad Sci U S A (1992) 1.11
Role of cytokines in the pathogenesis of autoimmune diabetes mellitus. Rev Endocr Metab Disord (2003) 1.11
Infliximab restores glucose homeostasis in an animal model of diet-induced obesity and diabetes. Endocrinology (2007) 1.09
Immune cell infiltration, cytokine expression, and beta-cell apoptosis during the development of type 1 diabetes in the spontaneously diabetic LEW.1AR1/Ztm-iddm rat. Diabetes (2005) 1.09
Dendritic cells and scavenger macrophages in pancreatic islets of prediabetic BB rats. Diabetes (1989) 1.06
Differential regulation of CHOP-10/GADD153 gene expression by MAPK signaling in pancreatic beta-cells. Proc Natl Acad Sci U S A (2007) 1.04
Inflammatory mechanisms in diabetes: lessons from the beta-cell. Int J Obes Relat Metab Disord (2003) 1.03
Tumor necrosis factor alpha gene regulation: enhancement of C/EBPbeta-induced activation by c-Jun. Mol Cell Biol (1998) 1.02
NFAT regulates insulin gene promoter activity in response to synergistic pathways induced by glucose and glucagon-like peptide-1. Diabetes (2002) 1.01
Effects of cytokines on rat pancreatic islet cell monolayer cultures: distinction between functional and cytotoxic effects on islet beta-cells. Reg Immunol (1990) 1.01
The role of TNF-alpha in the pathogenesis of type 1 diabetes in the nonobese diabetic mouse: analysis of dendritic cell maturation. Proc Natl Acad Sci U S A (2005) 0.99
Calcineurin/NFAT signaling in the beta-cell: From diabetes to new therapeutics. Bioessays (2007) 0.98
Human pancreatic duct cells can produce tumour necrosis factor-alpha that damages neighbouring beta cells and activates dendritic cells. Diabetologia (2004) 0.96
FK506 and ciclosporin: molecular probes for studying intracellular signal transduction. Trends Pharmacol Sci (1993) 0.95
Regulation of CCAAT/enhancer-binding protein homologous protein (CHOP) expression by interleukin-1 beta in pancreatic beta cells. J Biol Chem (2010) 0.94
High incidence of tacrolimus-associated posttransplantation diabetes in the Korean renal allograft recipients according to American Diabetes Association criteria. Diabetes Care (2003) 0.92
Multiple chromatin-bound protein kinases assemble factors that regulate insulin gene transcription. Proc Natl Acad Sci U S A (2009) 0.91
Identification of a calcium-inducible, cyclosporine sensitive element in the IFN-gamma promoter that is a potential NFAT binding site. Transplantation (1996) 0.90
Cytokines and diabetes: the final step? Involvement of TNF-alpha in both type I and II diabetes mellitus. Horm Metab Res (1994) 0.90
Massive parallel gene expression profiling of RINm5F pancreatic islet beta-cells stimulated with interleukin-1beta. APMIS (2000) 0.89
NFAT regulates calcium-sensing receptor-mediated TNF production. Am J Physiol Renal Physiol (2005) 0.89
Posttransplantation diabetes mellitus in FK-506-treated renal transplant recipients: analysis of incidence and risk factors. Transplantation (2001) 0.89
Cytokine gene expression in pancreatic islet-infiltrating leukocytes of BB rats: expression of Th1 cytokines correlates with beta-cell destructive insulitis and IDDM. Diabetes (1996) 0.89
Posttransplant diabetes mellitus in pediatric renal transplant recipients: a report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS). Transplantation (2001) 0.89
Gene microarray study corroborates proteomic findings in rodent islet cells. J Proteome Res (2003) 0.88
Tumor necrosis factor-alpha production by human islets leads to postisolation cell death. Transplantation (2006) 0.88
TNF receptor 1-dependent beta cell toxicity as an effector pathway in autoimmune diabetes. J Immunol (1999) 0.87
Tumor necrosis factor alpha signaling pathway and apoptosis in pancreatic beta cells. Metabolism (1999) 0.87
Low-dose interleukin 1 and tumor necrosis factor individually stimulate insulin release but in combination cause suppression. Eur J Endocrinol (1994) 0.87
The functional state of the beta cell modulates IL-1 and TNF-induced cytotoxicity. Lymphokine Cytokine Res (1993) 0.85
Role of the cyclosporin-sensitive transcription factor NFAT1 in the allergic response. Mem Inst Oswaldo Cruz (1997) 0.83
Interleukin-1-beta, tumor necrosis factor-alpha, insulin secretion and oral glucose tolerance in non-diabetic siblings of children with IDDM. Indian J Pediatr (2000) 0.81
Immunoregulation by cytokines in autoimmune diabetes. Adv Exp Med Biol (2003) 0.81
TNFalpha and leptin inhibit basal and glucose-stimulated insulin secretion and gene transcription in the HIT-T15 pancreatic cells. Int J Obes Relat Metab Disord (2001) 0.81
Both CD4(+)and CD8(+)T cells are required for IFN-gamma gene expression in pancreatic islets and autoimmune diabetes development in biobreeding rats. J Autoimmun (1999) 0.79
Cyclosporin-sensitive expression of cytokine mRNA in mouse macrophages responding to bacteria. Mol Immunol (1995) 0.78
Accelerated diabetes in rat insulin promoter-tumor necrosis factor-alpha transgenic nonobese diabetic mice lacking major histocompatibility class II molecules. Diabetes (2003) 0.78
Involvement of dendritic cells in early insulitis of BB rats. J Autoimmun (1992) 0.77
Impact of immunosuppressive regimes on posttransplant diabetes mellitus. Transplant Proc (2001) 0.76
Tumor necrosis factor activity of pancreatic islets. Am J Physiol (1997) 0.75
Posttransplantation Diabetes Mellitus in FK-506-Treated Renal Transplant Recipients: Analysis of Incidence and Risk Factors. Transplantation 2001; 72: 1655. Transplantation (2001) 0.75
Extracorporeal Membrane Oxygenation for 2009 Influenza A(H1N1) Acute Respiratory Distress Syndrome. JAMA (2009) 9.47
Use of normal tissue complication probability models in the clinic. Int J Radiat Oncol Biol Phys (2010) 4.33
Radiation dose-volume effects in radiation-induced rectal injury. Int J Radiat Oncol Biol Phys (2010) 3.83
Radiation dose-volume effects in the lung. Int J Radiat Oncol Biol Phys (2010) 3.73
Incidence of late rectal and urinary toxicities after three-dimensional conformal radiotherapy and intensity-modulated radiotherapy for localized prostate cancer. Int J Radiat Oncol Biol Phys (2008) 3.61
Improvement in outcomes of clinical islet transplantation: 1999-2010. Diabetes Care (2012) 3.20
Dose-volume factors contributing to the incidence of radiation pneumonitis in non-small-cell lung cancer patients treated with three-dimensional conformal radiation therapy. Int J Radiat Oncol Biol Phys (2002) 2.76
Involved-field radiation therapy for inoperable non small-cell lung cancer. J Clin Oncol (2007) 2.56
Quantitative Analyses of Normal Tissue Effects in the Clinic (QUANTEC): an introduction to the scientific issues. Int J Radiat Oncol Biol Phys (2010) 2.32
Lipid bilayer structure determined by the simultaneous analysis of neutron and X-ray scattering data. Biophys J (2008) 2.27
The presence of multiple regions of homozygous deletion at the CSMD1 locus in oral squamous cell carcinoma question the role of CSMD1 in head and neck carcinogenesis. Genes Chromosomes Cancer (2003) 2.24
Telomeric expression sites are highly conserved in Trypanosoma brucei. PLoS One (2008) 2.22
Intensity-modulated radiation therapy (IMRT) for inoperable non-small cell lung cancer: the Memorial Sloan-Kettering Cancer Center (MSKCC) experience. Radiother Oncol (2008) 2.08
Acute kidney injury following liver transplantation: definition and outcome. Liver Transpl (2009) 2.05
Correlation of dosimetric factors and radiation pneumonitis for non-small-cell lung cancer patients in a recently completed dose escalation study. Int J Radiat Oncol Biol Phys (2005) 2.02
Volumetric modulated arc therapy: planning and evaluation for prostate cancer cases. Int J Radiat Oncol Biol Phys (2009) 1.97
Equatorially dominated magnetic field change at the surface of Earth's core. Science (2003) 1.94
GeneDB--an annotation database for pathogens. Nucleic Acids Res (2011) 1.82
The roles of MAPKs in disease. Cell Res (2008) 1.76
Analyzing habituation responses to novelty in zebrafish (Danio rerio). Behav Brain Res (2009) 1.69
FGF9 suppresses meiosis and promotes male germ cell fate in mice. Dev Cell (2010) 1.64
Results of a phase I dose-escalation study using three-dimensional conformal radiotherapy in the treatment of inoperable nonsmall cell lung carcinoma. Cancer (2005) 1.57
Improved local control with higher doses of radiation in large-volume stage III non-small-cell lung cancer. Int J Radiat Oncol Biol Phys (2004) 1.56
Twenty years of follow-up of aortohepatic conduits in liver transplantation. Liver Transpl (2008) 1.53
Stimulation of human and rat islet beta-cell proliferation with retention of function by the homeodomain transcription factor Nkx6.1. Mol Cell Biol (2008) 1.52
Preoperative and perioperative predictors of the need for renal replacement therapy after orthotopic liver transplantation. Transplantation (2004) 1.50
ERK1/2-dependent activation of transcription factors required for acute and chronic effects of glucose on the insulin gene promoter. J Biol Chem (2005) 1.48
Radiation therapy and hearing loss. Int J Radiat Oncol Biol Phys (2010) 1.46
The use and QA of biologically related models for treatment planning: short report of the TG-166 of the therapy physics committee of the AAPM. Med Phys (2012) 1.46
Improving normal tissue complication probability models: the need to adopt a "data-pooling" culture. Int J Radiat Oncol Biol Phys (2010) 1.44
Syndromic incidence of ovarian carcinoma after liver transplantation, with special reference to anteceding breast cancer. Dig Dis Sci (2003) 1.43
A novel small-angle neutron scattering detector geometry. J Appl Crystallogr (2013) 1.39
Estimating the volume of chronic pleural effusions using transesophageal echocardiography. J Cardiothorac Vasc Anesth (2011) 1.39
An autonomous implantable computer for neural recording and stimulation in unrestrained primates. J Neurosci Methods (2005) 1.38
Learning a novel myoelectric-controlled interface task. J Neurophysiol (2008) 1.36
Regulation of ERK1 and ERK2 by glucose and peptide hormones in pancreatic beta cells. J Biol Chem (2003) 1.33
The G protein-coupled taste receptor T1R1/T1R3 regulates mTORC1 and autophagy. Mol Cell (2012) 1.29
Sensorineural hearing loss in combined modality treatment of nasopharyngeal carcinoma. Cancer (2006) 1.28
Thrombendvenectomy for organized portal vein thrombosis at the time of liver transplantation. Ann Surg (2002) 1.24
Chromatin-bound mitogen-activated protein kinases transmit dynamic signals in transcription complexes in beta-cells. Proc Natl Acad Sci U S A (2008) 1.23
Extracorporeal membrane oxygenation for severe ARDS in pregnant and postpartum women during the 2009 H1N1 pandemic. Intensive Care Med (2011) 1.22
Seven consecutive successful clinical islet isolations with pancreatic ductal injection. Cell Transplant (2009) 1.21
Pig cells that lack the gene for alpha1-3 galactosyltransferase express low levels of the gal antigen. Transplantation (2003) 1.21
Methodological issues in radiation dose-volume outcome analyses: summary of a joint AAPM/NIH workshop. Med Phys (2002) 1.20
Large human islets secrete less insulin per islet equivalent than smaller islets in vitro. Islets (2011) 1.20
A correlation between the pretransplantation MELD score and mortality in the first two years after liver transplantation. Liver Transpl (2003) 1.20
Improving efficacy of clinical islet transplantation with iodixanol-based islet purification, thymoglobulin induction, and blockage of IL-1β and TNF-α. Cell Transplant (2011) 1.18
Flexible cortical control of task-specific muscle synergies. J Neurosci (2012) 1.14
Predicting renal failure after liver transplantation from measured glomerular filtration rate: review of up to 15 years of follow-up. Transplantation (2010) 1.13
Reanimating the arm and hand with intraspinal microstimulation. J Neural Eng (2011) 1.12
An outcome comparison between primary liver transplantation and retransplantation based on the pretransplant MELD score. Transpl Int (2006) 1.11
The finished DNA sequence of human chromosome 12. Nature (2006) 1.08
Intensity-modulated radiotherapy. Cancer J (2002) 1.07
Slower Walking Speed Forecasts Increased Postoperative Morbidity and 1-Year Mortality Across Surgical Specialties. Ann Surg (2015) 1.07
Iodixanol-controlled density gradient during islet purification improves recovery rate in human islet isolation. Transplantation (2009) 1.07
Surgical Ward Round Quality and Impact on Variable Patient Outcomes. Ann Surg (2015) 1.07
Pretransplant MELD score as a predictor of outcome after liver transplantation for chronic hepatitis C. Am J Transplant (2003) 1.05
The Genboree Microbiome Toolset and the analysis of 16S rRNA microbial sequences. BMC Bioinformatics (2012) 1.05
Increased water retention in polymer electrolyte membranes at elevated temperatures assisted by capillary condensation. Nano Lett (2007) 1.04
Differential regulation of CHOP-10/GADD153 gene expression by MAPK signaling in pancreatic beta-cells. Proc Natl Acad Sci U S A (2007) 1.04
Geometric factors influencing dosimetric sparing of the parotid glands using IMRT. Int J Radiat Oncol Biol Phys (2006) 1.04
Low-temperature preservation of isolated islets is superior to conventional islet culture before islet transplantation. Transplantation (2010) 1.01
Abstract and proportional myoelectric control for multi-fingered hand prostheses. Ann Biomed Eng (2013) 1.01
Esophageal toxicity from high-dose, single-fraction paraspinal stereotactic radiosurgery. Int J Radiat Oncol Biol Phys (2012) 1.00
De novo tumors after liver transplantation: a single-institution experience. Liver Transpl (2002) 1.00
Risk group dependence of dose-response for biopsy outcome after three-dimensional conformal radiation therapy of prostate cancer. Radiother Oncol (2002) 1.00
Technological advances in external-beam radiation therapy for the treatment of localized prostate cancer. Semin Oncol (2003) 1.00
Fresh islets are more effective for islet transplantation than cultured islets. Cell Transplant (2012) 1.00
Two-stage total hepatectomy and liver transplantation for acute deterioration of chronic liver disease: a new bridge to transplantation. Liver Transpl (2004) 1.00
Characterization and gene expression analysis of the cir multi-gene family of Plasmodium chabaudi chabaudi (AS). BMC Genomics (2012) 0.99
Evaluation of osmolality of density gradient for human islet purification. Cell Transplant (2012) 0.99
Liver retransplantation for primary nonfunction: analysis of a 20-year single-center experience. Liver Transpl (2007) 0.99
Thrombotic microangiopathy associated with interferon beta. N Engl J Med (2014) 0.97
Pancreatic islet cell transplantation: a treatment strategy for type I diabetes mellitus. Nutr Clin Pract (2004) 0.96
Late acute rejection after liver transplantation impacts patient survival. Clin Transplant (2008) 0.96
Warfarin or low-molecular-weight heparin therapy does not prolong pig-to-primate cardiac xenograft function. Am J Transplant (2005) 0.96
Liver and kidney transplantation for polycystic liver and kidney-renal function and outcome. Transplantation (2006) 0.96
Dose-volume parameters predict for the development of chest wall pain after stereotactic body radiation for lung cancer. Int J Radiat Oncol Biol Phys (2011) 0.95
Low rate of thoracic toxicity in palliative paraspinal single-fraction stereotactic body radiation therapy. Radiother Oncol (2009) 0.95
The effects of chronic social defeat stress on mouse self-grooming behavior and its patterning. Behav Brain Res (2010) 0.95
Variables associated with islet yield in autologous islet cell transplantation for chronic pancreatitis. Proc (Bayl Univ Med Cent) (2010) 0.94
Reduced-order parameter optimization for simplifying prostate IMRT planning. Phys Med Biol (2007) 0.94
Endogenous Nodal signaling regulates germ cell potency during mammalian testis development. Development (2012) 0.94
Characterization of human pancreatic progenitor cells. Cell Transplant (2010) 0.93